Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Similar Posts
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….
Masks back in hospitals, the 30 best diets, and screen time warnings
Some hospitals have reactivated mask mandates in response to a rise in COVID-19 cases and influenza respiratory infections, although the current increase is minimal compared to the spikes seen during the pandemic. (iStock) BACK TO MASKING – Some hospitals in New York and several other states have reinstated mask mandates. Here’s what doctors have to…
Hugh Jackman Might Have Skin Cancer And Is Taking The Opportunity To Remind People To Wear Sunscreen
This isn’t the first time Jackman has reminded people to wear their sunscreen in an Instagram post. In 2013, Jackman revealed he had basal cell carcinoma on his nose, adding, “Get yourself checked. And USE sunscreen!!!” Similarly, Khloé Kardashian recently had two biopsies after noticing a small bump on her cheek that wouldn’t go away,…
Ellie Middleton: ‘Learning the way my brain works has changed everything for me’
Author Ellie Middleton on her late ADHD and autism diagnoses.
Parkinson’s disease: ‘You can have a career after diagnosis’
A spokesperson for NHS England said: “While local NHS trusts are each responsible for their own medicines policy, NHS England has commissioned a range of support, information and resources for organisations on this issue, which have been used by hundreds of health professionals – we will continue to encourage their use so patients in hospital…
Patient saw eight GPs before cancer spotted
Safety watchdog highlights case as it warns a lack of continuity of care in England puts people at risk.
